Skip to content

Clinical trials

Phase 1 Multiple Endocrine Neoplasia Type 1 trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Endocrine Neoplasia Type 1 Phase: Phase 1 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20101
20142
20161
20172
20181
20217
20224
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer12
GlaxoSmithKline2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
Hvidovre University Hospital1
M.D. Anderson Cancer Center1
Medical College of Wisconsin1
Syracuse University1
University of Eastern Finland1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Endocrine Neoplasia Type 122
Hot Flashes7
Neuroendocrine Tumors2
Adrenal Cortex Neoplasms1
Carcinoid Tumor1
Carcinoma, Medullary1
Carcinoma, Merkel Cell1
Eunuchism1
Glucagonoma1
Hypogonadism1

Trials

Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.